Quan Du

Title: The Innovative Contributions of Quan Du

Introduction

Quan Du is a notable inventor based in the Bronx, NY (US). He has made significant contributions to the field of cancer therapeutics, particularly through his work on DNA methyltransferase inhibitors. With a total of 2 patents, his innovations are paving the way for new treatments in oncology.

Latest Patents

One of Quan Du's latest patents is titled "Inhibitors of DNMT1 as anticancer therapeutic agents." This invention provides inhibitors of DNA methyltransferase 1, an enzyme crucial for maintaining DNA CpG methylation marks in human cells. The patent details compounds, pharmaceutical compositions, and methods for effectively inhibiting DNA methyltransferase 1. Another significant patent is "DNA methyltransferase 1 transition state structure and uses thereof." This patent discloses methods and systems for obtaining inhibitors of human DNA methyltransferase 1, focusing on designing compounds that resemble the DNMT1 transition state.

Career Highlights

Throughout his career, Quan Du has worked with esteemed institutions, including Albert Einstein College of Medicine and Victoria Link Limited. His work has been instrumental in advancing the understanding and treatment of cancer through innovative approaches.

Collaborations

Quan Du has collaborated with notable individuals in his field, including Vern L Schramm and Peter Charles Tyler. These collaborations have further enriched his research and contributions to cancer therapeutics.

Conclusion

In summary, Quan Du's innovative work in developing inhibitors for DNA methyltransferase 1 showcases his commitment to advancing cancer treatment. His patents and collaborations reflect a dedication to improving therapeutic options for patients.